Qualcomm-Arm Licensing Trial Ends Without Verdict
A Delaware jury deliberated for about four hours without reaching a verdict in Qualcomm's licensing lawsuit against Arm, and is set to return Tuesday. Qualcomm alleges Arm withheld software patches and tools, violated pricing terms, and leaked a letter that harmed its dealings with Meta; Arm argues Qualcomm was not harmed. The dispute centers on Qualcomm's license for Arm's architecture through 2033 and terms for newer versions.
The Delaware jury spent roughly four hours Friday without deciding Qualcomm’s claims against Arm. It will resume Tuesday. This is the companies’ second trial in two years. Qualcomm contends Arm withheld software updates and development tools, breached a pricing term tied to Arm’s lowest processor-design price, and shared a 2024 Bloomberg letter about an alleged license breach, affecting Meta talks. Arm denies Qualcomm was harmed and calls the case leverage.
Qualcomm’s architecture license extends to 2033, but newer versions remain unresolved. A separate bench trial examines whether Arm negotiated in good faith; its ruling may arrive after the jury. Qualcomm recently posted $9.9 billion quarterly revenue and $2.21 EPS, with record automotive sales and growth in non-handset areas.
The unresolved trial may keep uncertainty around Qualcomm and Arm, affecting investors and companies that rely on their chip designs. If licensing terms remain contested, smartphone, automotive, and data-center supply chains could face delays or cost pressure, potentially influencing device prices and innovation. Workers and consumers may feel effects indirectly through product availability and pricing, though the jury’s eventual decision could clarify the outlook.